The Priority Review

Tag

Apellis Pharmaceuticals

1 story

  1. Clinical trials

    Apellis posts results of Phase 3 extension study of pegcetacoplan in geographic atrophy

    The study enrolled 792 participants and completed primary data collection on September 5, 2025. Results were first posted on ClinicalTrials.gov on October 28, 2026.